Evidence map›Paper›PMID 31211416›Full record

Trial reportJournal of the American Geriatrics Society2019

Effect of Vitamin K2 on Postural Sway in Older People Who Fall: A Randomized Controlled Trial.

Miles D Witham, Rosemary J G Price, Margaret M Band, Michael S Hannah, Roberta L Fulton, Clare L Clarke, Peter T Donnan, Paul McNamee, Vera Cvoro, Roy L Soiza

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Geriatrics Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Vitamin K intake and health, consideration from the epidemiological studies.Journal of clinical biochemistry and nutrition · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Miles D WithamAGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals Trust, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-1967-0990
Rosemary J G PriceTayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.
Margaret M BandTayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.
Michael S HannahTayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.
Roberta L FultonSchool of Nursing, Abertay University, Dundee, United Kingdom.
Clare L ClarkeTayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.
Peter T DonnanTayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.
Paul McNameeHealth Economics Research Unit, University of Aberdeen, Aberdeen, United Kingdom.
Vera CvoroCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK and NHS Fife, Kirkcaldy, United Kingdom.
Roy L SoizaAgeing Clinical and Experimental Research, School of Medicine & Dentistry, University of Aberdeen, Aberdeen, United Kingdom.
University of Dundee · GBUniversity of Aberdeen · GBAbertay University · GBNHS Fife · GB

Funding

Chief Scientist Office HERU1
6 · The paper itself

Abstract

objectivesVitamin K is thought to be involved in both bone health and maintenance of neuromuscular function. We tested the effect of vitamin K2 supplementation on postural sway, falls, healthcare costs, and indices of physical function in older people at risk of falls.

designParallel-group double-blind randomized placebo-controlled trial.

settingFourteen primary care practices in Scotland, UK.

participantsA total of 95 community-dwelling participants aged 65 and older with at least two falls, or one injurious fall, in the previous year.

interventionOnce/day placebo, 200 μg or 400 μg of oral vitamin K2 for 1 year. MEASUREMENTS: The primary outcome was anteroposterior sway measured using sway plates at 12 months, adjusted for baseline. Secondary outcomes included the Short Physical Performance Battery, Berg Balance Scale, Timed Up & Go Test, quality of life, health and social care costs, falls, and adverse events.

resultsMean participant age was 75 (standard deviation [SD] = 7) years. Overall, 58 of 95 (61%) were female; 77 of 95 (81%) attended the 12-month visit. No significant effect of either vitamin K2 dose was seen on the primary outcome of anteroposterior sway (200 μg vs placebo: -.19 cm [95% confidence interval [CI] -.68 to .30; P = .44]; 400 μg vs placebo: .17 cm [95% CI -.33 to .66; P = .50]; or 400 μg vs 200 μg: .36 cm [95% CI -.11 to .83; P = .14]). Adjusted falls rates were similar in each group. No significant treatment effects were seen for other measures of sway or secondary outcomes. Costs were higher in both vitamin K2 arms than in the placebo arm.

conclusionOral vitamin K2 supplementation did not improve postural sway or physical function in older people at risk of falls. J Am Geriatr Soc 67:2102-2107, 2019.

Indexed as

Postural BalanceAccidental FallsAgedDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansMaleVitamin K 2VitaminsVitamin K 2Vitaminsfallshealth economic analysispostural swayrecruitmentvitamin K

Identifiers

PMID31211416
PMCPMC6851824
OpenAlexW2952343273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.